Mental healthcare company focused on accelerating patient access to evidence-based innovation in mental health COMPASS Pathways PLC. (CMPS) announced having filed for its fourth provisional patent application with the United States Patent and Trademark Office (UPTSO).
This patent filing concerns a solid form of psilocybin known as Hydrate which also contains water molecules within its structure.
The company says this patent application unlike the others, was allowed without a single rejection after the examiner found ‘the closet prior art of record’ indicating that the solid psilocybin forms solvates but nothing ‘indicates polymorphism’.
This application was filed under UPTSO’s ‘Track One’ which is normally used to protect a patent application from third party prior art submissions because examination may already be over by the time an application is announced to the public.